Le Lézard
Classified in: Health
Subjects: CHI, TRI

Moorfields Eye Hospital Dubai Consultant Ophthalmologist Treats Complex Congenital Visual Impairments in Teenage UAE Patient


DUBAI, UAE, November 29, 2017 /PRNewswire/ --

Moorfields Eye Hospital Dubai has successfully treated a young patient - 15 year old Rabaa Arif Khalid Ahmed Alyassi - for a severe visual impairment from birth caused by bilateral congenital cataracts (clouding of the lens), nystagmus (a condition in which the eyes make repetitive, uncontrolled movements) and degenerative myopia (shortsightedness). The hospital team undertook a complex surgical procedure to implant custom made intraocular lenses in both eyes, with very good recovery and end results for the patient. For the first time, Rabaa can see without glasses and now only wears them for reading at school.  

     (Photo: http://mma.prnewswire.com/media/612280/Dr_Darakhshanda_Khurram.jpg )

Rabaa visited Dr Darakhshanda Khurram wearing very thick lenses in her glasses because of her severe cataract and myopia (Right eye -19.00 DS, Vision 0.9 LogMar and left eye -19.00 DS, Vision 1.1 LogMar). She was unable to read without holding the book very close to her face and this affected her quality of life.

A cataract is a clouding of the eye's natural lens, behind the iris and the pupil. Cataracts are the most common cause of vision loss in people over the age of 40 and the main cause of blindness in the world, so a teenage patient is relatively unusual. Congenital cataracts means the problem was present at birth and may be relatively insignificant or they can lead to severe visual impairment. Congenital cataracts may affect one or both eyes.

Following detailed examinations, the Moorfields team decided to perform a very complex cataract extraction procedure, combined with a lens implant, supported by the hospital's advanced technology.

Because of Rabaa's large eyes and complex cataracts, the hospital had to order especially powerful intraocular lenses for her eyes. She under went surgery first on the left eye followed by the right eye. Her postoperative recovery was excellent and two months after surgery her vision was: Right eye 0.40, Left eye 0.40.

Commenting on Rabaa's condition and treatment, Dr. Darakhshanda Khurram,

Consultant Paediatric Ophthalmologist at Moorfields Eye Hospital Dubai and Al Jalila Children's, said: "Rabaa had a complex combination of conditions, with high myopia and dense cataract at such a young age; this was badly affecting the quality of her life and so we decided to go ahead with this complex procedure to help her, and we are all delighted with the excellent results; we will just continue regular monitoring of her eyes. Rabaa's case does highlight the importance of early and regular eye examinations for children because early treatment can significantly reduce the risk of long-term vision problems."

Notes to editors

About Moorfields Eye Hospital Dubai 

Moorfields Eye Hospital Dubai (MEHD) is the first overseas branch of Moorfields Eye Hospital NHS Foundation Trust, the oldest and one of the largest centres for ophthalmic treatment, teaching and research in the world. Located at the Al Razi Medical Complex in Dubai Health Care City, the facility provides day case surgery and outpatient diagnostic and treatment services, for a variety of surgical and non-surgical eye conditions. MEHD will also raise standards for research and teaching in the region. MEHD is owned and managed by the NHS Foundation Trust, and maintains close links with London, to ensure that patients in the GCC receive the best eye care treatment in the world.


These press releases may also interest you

at 08:38
Empower Community Care, a leading global behavioral health and education organization, is thrilled to announce that it has been honored with the prestigious Pacesetter Award for 2024. Presented annually by the Atlanta Business Chronicle, the...

at 08:35
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor...

at 08:35
Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice...

at 08:33
1MD Nutrition, a leading developer of physician-formulated, condition-specific nutritional supplements with key ingredients in therapeutically significant dosages from substantiated, human clinical trials, is now a "Proud Partner" of the...

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...



News published on and distributed by: